Bonraybio Co., Ltd. (TPE:6955)

Bonraybio Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	196.64	271.25	410.17	116.87	89.42	70.02
Short-Term Investments	339	302	117.6	117.6	127.4	131.54
Cash & Short-Term Investments	535.64	573.25	527.77	234.47	216.82	201.56
Cash Growth	5.53%	8.62%	125.09%	8.14%	7.57%	192.84%
Accounts Receivable	38.91	25.37	18.22	13.25	3.88	3.77
Other Receivables	0.33	0.27	0.15	0.17	0.1	0.05
Receivables	39.25	25.64	18.37	13.41	3.98	3.82
Inventory	51.01	41.64	27.62	19.23	17.01	15.87
Prepaid Expenses	13.01	7.37	3.31	4.61	-	3.25
Other Current Assets	1	2.95	0.44	0.25	2.96	0.01
Total Current Assets	639.9	650.84	577.5	271.97	240.77	224.52
Property, Plant & Equipment	17.45	18.39	17.42	23.63	16.69	16.96
Other Intangible Assets	25.48	23.98	16.19	13.91	13.09	12.64
Long-Term Deferred Tax Assets	1.04	0.81	-	-	-	-
Other Long-Term Assets	39.03	25.85	11.69	7.75	9.48	8.49
Total Assets	722.89	719.87	622.8	317.26	280.03	262.61

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.22	2.06	4.23	2.73	2.83	2.62
Accrued Expenses	29.87	39.22	29.4	19.1	12.46	9.3
Short-Term Debt	-	15	-	-	-	-
Current Portion of Leases	3.48	3.4	3.26	3.08	3.02	2.87
Current Income Taxes Payable	8.58	2.55	-	-	-	-
Current Unearned Revenue	2.03	6.3	5.38	1.25	1.77	0.19
Other Current Liabilities	13.94	6.2	2.22	2.44	4.08	4.53
Total Current Liabilities	64.11	74.73	44.49	28.59	24.15	19.52
Long-Term Leases	1.78	3.55	6.95	10.21	3.08	6.09
Long-Term Deferred Tax Liabilities	0.28	0.18	-	-	-	-
Total Liabilities	66.17	78.47	51.45	38.81	27.23	25.62

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	248.01	248.01	215.66	170.86	170.86	16.14
Additional Paid-In Capital	251.14	269.74	280.53	80.51	80.51	324.13
Retained Earnings	101.8	123.87	75.28	27.41	1.69	-103.1
Comprehensive Income & Other	55.77	-0.21	-0.11	-0.33	-0.26	-0.18
Shareholders' Equity	656.72	641.41	571.35	278.46	252.8	236.99
Total Liabilities & Equity	722.89	719.87	622.8	317.26	280.03	262.61

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.26	21.95	10.22	13.29	6.09	8.96
Net Cash (Debt)	530.38	551.29	517.55	221.19	210.72	192.6
Net Cash Growth	6.29%	6.52%	133.99%	4.96%	9.41%	237.06%
Net Cash Per Share	17.38	18.08	18.52	7.98	8.44	9.88
Filing Date Shares Outstanding	30.38	30.38	30.38	27.68	27.68	22.1
Total Common Shares Outstanding	30.38	30.38	30.38	27.68	27.68	22.1
Working Capital	575.79	576.11	533.01	243.38	216.62	205
Book Value Per Share	21.62	21.11	18.81	10.06	9.13	10.72
Tangible Book Value	631.24	617.43	555.16	264.55	239.71	224.35
Tangible Book Value Per Share	20.78	20.32	18.27	9.56	8.66	10.15
Machinery	17.28	16.08	15.98	17.97	14.05	11.8
Leasehold Improvements	5.29	4.76	4.03	3.99	6.91	11.35

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error